1.April 15, 2023 云南大学统计学、数据科学学科发展建设高端论坛， 昆明
2.April 8, 2023 真实世界研究中的因果推断，中国创新药物（械）医学大会暨CMAC年会，苏州
3.April 2, 2023 因果推断在药品医疗器械监管科学中的应用，第六届中国药品监管科学大会，北京
4.March 30, 2023 因果推断在药品医疗器械监管科学中的应用，太极集团首届科技创新大会，重庆
5.March 25, 2023 Statistical Methods for Evaluation of AI-based Medical Diagnostic System, 数学肿瘤研讨会III，温州
6.March 18, 2023 中医临床疗效评价因果方法，2023世界中联中医药大数据产业高峰论坛，重庆
7.February 25, 2023 因果推断在临床研究应用：现状和将来, 第四届中国医药统计高峰论坛，上海
8.February 24, 2023 Design and Analysis for Clinical Study of AI-Based Medical Devices, Peking University, Beijing
9.February 16, 2023数学和医学的交叉学科：生物统计学科, 石景山区医院综合管理中心讲座，北京
10.November 30, 2022 Causal Inference with Truncation-by-Death and Unmeasured Confounding 东北大学数学与统计学院统计学专题报告online
11.October 31, 2022 生物统计学科。儿童营养与生长发育优发展临床研究联盟系列讲座。online
12.October 27, 2022 医学和数学的交叉学科。 北京大学才斋讲堂。
13.September 18, 2022 Causal Inference of Truncation-by-Death with Unmeasured Confounding The 2022 Pacific Causal Inference Conference Academic Report, online
14.August 27, 2022 Causal Inference in the Presence of Unmeasured Confounders 中国生物统计2022学术年会online
15.May 24,2022 A novel regression method for the analysis of MRMC-FROC Studies with application to evaluation of AI-based computer-aided diagnostic systems 复旦大学子彬论坛online
16.December 20, 2019. Estimation of Optimal Individualized Treatment Rule Using the Covariate-Specific Treatment Effect Curve with High-dimensional Covariates. International Chinese Statistical Association International Conference. Zhejiang, China.
17.October 3, 2019. Statistical Methods for Finding Optimal Treatment Rule. One-hour invited talk. Fred Hutchinson Cancer Center. Seattle, WA, USA.
18.September 20, 2019. Statistical Methods for Evaluation of AI-Based Medical Devices. 中国工业与应用数学学会第十七届年会大会50分钟发言。广东佛山，中国
19.April 9, 2019. Statistical Method for Selecting Optimal Treatment with High-dimensional Covariates. One-hour invited talk. Chinese University of Hong Kong. Hong Kong, China.
20.October 21, 2018. 因果推断的数学基础及在生物统计中的应用。中国数学学会年会大会50分钟发言。贵州，中国
21.July 26-29, 2016. Big Data Analysis in Precision Medicine. China Biostatistics Conference (中国生物统计 2016 年学术年会大会发言). Statistics and Big Data. Tianjin, China.
22.September 28-30, 2016. Selection the optimal treatment with conditional quantile treatment effect curve. 2016 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop. Washington DC, USA.
23.December 19, 2016. Dealing with Truncation by Death in Causal Inference from Observational Data. The 10th ICSA International Conference: Shanghai, China.
24.March 4, 2016. Box-Cox Transformation Model for Skewed Mark Variable. Department of Biostatistics, John Hopkins University. Baltimore, MD, USA.
25.April 29, 2016. Predicting Life-time Medical Cost with Censored Data. Department of Biostatistics, Indiana University. Indianapolis, IN, USA.
26.August 3, 2016. Quantile-based Method for Choosing Optimal Treatments, Using Biomarkers. Chicago, IL, USA.
27.October 20, 2016. Statistical Methods for Analysis of Potentially Censored Skewed Data with an Application to Health Care Costs. School of Mathematical Science, Peking University, Beijing, China.
28.December 17, 2016. Estimation of Causal Effects of a New Treatment on Patient’s Outcomes Truncated by Deaths. 第十届临床医学研究中的统计方法学术研讨会-大数据背景下的传承与创新。Beijing, China.
29. December 24, 2016. Using the Treatment Benefit Rate and Treatment Harm Rate to Assess the Heterogeneity of Treatment Effects. Center for Statistical Science, Sichuan University. Chengdu, China
30. December 17, 2016. Longitudinal Studies in Neurology Research with an Application to Alzheimer’s Disease. 中国医疗保健国际交流促进会中老年医疗保健分会暨2016神经疾病高峰论坛。Beijing, China.
31.October 16-19, 2013. Design and Analysis of Postmarketing Studies. The International Conference on Postmarketing Surveillance of Chinese Medicines. Beijing, China.
32.Aug. 7, 2013. Causal Mediation Analysis on Survival Outcomes in Comparative Effectiveness Research. Joint Statistical Meetings (JSM), Montréal, Canada.
33.August 6, 2013. Causal Mediation Analysis in Comparative Effectiveness Research. Joint Statistical Meetings 2013. Montreal, Canada.
34.July 7, 2013. Causal inference with propensity score in the presence of missing outcome data (Keynote Speaker). Joint Conference of the Fifth Annual International Symposium of Clinical Trials and the Fourth East Asia Regional Biometric Conference. Beijing, China.
35.July 1, 2013. Generalized Partially Linear Models for Incomplete Longitudinal Data In the Presence of Population-Level Information. IMS-China International Conference on Statistics and Probability 2013. Chengdu, China.
36.June 8, 2013. Causal Inference in Broken Randomized Clinical Trials. Drug Clinical Trials for Evaluation of New Drugs Advanced Seminar. Beijing, China.
37.December 30, 2012. Statistical Inferences for the Analysis of Health Care Costs. Workshop on Modern Statistical. Shanghai University of Finance and Economics. Shanghai, China.
38.April 2. 2012. Semiparametric estimation of the covariate-specific ROC curve in presence of ignorable and non-ignorable verification bias. Eastern North American Region of the International Biometric Society (ENAR). Washington DC, USA.
39.April 8, 2012. Designs and Sample Size Calculation for Postmarketing Studies. First International Workshop on Safety Surveillance of Post-market of Chinese Medicine. Beijing, China.
40.April 2. 2012. Semiparametric estimation of the covariate-specific ROC curve in presence of ignorable and non-ignorable verification bias. Eastern North American Region of the International Biometric Society (ENAR). Washington DC, USA.
41.April 8, 2012. Designs and Sample Size Calculation for Postmarketing Studies. First International Workshop on Safety Surveillance of Post-market of Chinese Medicine. Beijing, China.
42.May 24, 2012. Optimal treatment Selection. 2012 Atlantic Causal Inference Conference. Baltimore, MD, USA.
43.June 23, 2012. Causal Inference in Randomized Clinical Trial. Advanced Seminar on Clinical Evaluation of New Drugs. Beijing, China.
44.June 26, 2012. Quantile Regression-Based Covariate-Specific ROC Curves. International Workshop on the Frontier of Statistics. Yunnan, China.
45.July 7, 2012. Designs in Evaluation of Medical Devices. Second Joint Biostatistics Symposium. Beijing, China.
46.July 8, 2012. Latent-Variable Marginal Method for Multi-Level Incomplete Binary Data. Second Joint Biostatistics Symposium. Beijing, China.
47. July 31, 2012. Identifiability and Estimation of Causal Effects of a New Treatment on Patient’s Outcomes Truncated by Deaths. Joint Statistical Meetings (JSM). San Diego, CA, USA.
48.September 27, 2012. Semiparametric estimation of the covariate-specific ROC curve. University of New York at Buffalo. Buffalo, NY, USA.
49.December 30, 2012 Prediction of Skewed Health Care Costs. the Frontier of Modern Statistics Workshop. Shanghai, China.
50.August 2, 2011. Empirical Likelihood-Based Method Using Calibration for Longitudinal Data with Drop-Out. Joint Statistical Meetings. San Diego, CA, USA.
51.July 7, 2011. Assessing Predictive Biomarkers in Selecting a Best Treatment using BATE Curve. The 3rd IMS-China International Conference on Statistics and Probability. Xian, China.
52.July 4, 2011. Estimating the accuracy of diagnostic tests in the presence of verification bias. The Fourth Military Medical University. Xian, China.
53.July 2, 2011. Disease Progression Models with an Application to Alzheimer's Disease. The Fourth International Symposium on Clinical evaluation and application. Beijing, China.
54.June 8, 2011. Roles of Biostatistics in Advancement of Evidence-based and Personalized Medicine. Harbin Medical University. Harbin, China.
55.June 20, 2011. Semiparametric estimation of the covariate-specific ROC curve. Chinese Academy of Sciences. Beijing, China.
56.March 21, 2011. A Procedure for Evaluating Predictive Accuracy of Biomarkers for Selecting Optimal Treatment. Eastern North American Region of the International Biometric Society (ENAR). Miami, Florida, USA.
57.August 16, 2010. Clinical and statistical evaluation of diagnostic agents in compliance with FDA guidelines). China Heart Congress & International Heart Forum. Beijing, China.
58.July 18, 2010. Biostatistics in Public Health and Medicine. Department of Mathematics and Physics, China University of Petroleum. Beijing, China.
59.July 7, 2010. Doubly Robust Estimation for Binary Longitudinal Data Analysis with Missing Response and Missing Covariates. An International Conference in Honor of P.L. Hsu’s 100th Birthday, Peking University. Beijing, China.
60.July 10, 2010. Semi-parametric methods for correcting for verification bias under both ignorable and non- ignorable verification. The fourth International Forum on Statistics. Beijing, China.
61.July 18, 2010. Semi-parametric methods for correcting for verification bias under both ignorable and non-ignorable verification. First Joint Biostatistics Symposium. Beijing, China.
62.July 3, 2010. BATE Curve in Assessed of Clinical Utility of Predictive Biomarkers. Department of Biostatistics, the Second Military Medical University, Shanghai, China.
63.July 1, 2010. An Introduction to Survival Analysis in Medical Research. Department of Biostatistics, Chongqing Medical University. Chongqing, China.
64.March 23, 2010. A Procedure for Evaluating Predictive Accuracy of Biomarkers for Selecting Optimal Treatment. Eastern North American Region of the International Biometric Society (ENAR). New Orleans, USA.
65.August 3, 2009. Some New Models for Predicting Health Care Costs of Individual Patients. Joint Statistical Meetings. Washington DC, USA
66.July 18, 2009. Analysis of correlated right-skewed semi-continuous data with a semi-parametric two-part mixed-effects transformation model. International Conference on Statistics and Management, Shanghai University of Finance and Economics. Shanghai, China.
67.June 27, 2009. Evaluation of Diagnostic tests in TCM, a keynote speaker at Third Annual International Symposium on the Evaluation of Clinical Trials Methodologies, Renmin University. Beijing, China.
68.April 29, 2009. Evaluating Markers for Treatment Selection Based on Survival Time. Statistical Issues in Developing Targeted Therapies. University of Pennsylvania Annual Conference on Statistical Issues in Clinical Trials: From Bench to Bedside to Com-munity. Philadelphia, PA, USA.
69.December 23, 2008. Evaluation of Prognostic Accuracy of Biomarkers, Peking University. Beijing, China.
70.December 1, 2008. Evaluation of Prognostic Accuracy of Biomarkers. Mayo Clinic, Rochester, MN, USA.
71.Nov 3, 2008. Development of biomarkers: from exploration to qualification of clinical utility for therapeutics. FDA Center for Drug Evaluation and Research Visiting Professor Lecture Series. Silver Spring, MD, USA.
72.Oct 6, 2008. Non-parametric heroscedastic transformation regression models for skew-ed data with an application to prediction of future health care costs. College of Public Health, Ohio State University. Columbus, OH, USA.
73.August 5, 2008. A semi-parametric two-part mixed-effects model for longitudinal skewed semi-continuous data. Joint Statistical Meetings. Denver, TX, USA.
74.July 7, 2008. Selection and combining biomarkers for disease prediction. Chongqing University of Medical Sciences. Chongqing, China.
75.July 1, 2008. Identifiability and Estimation of Causal Effects in Randomized Trials with Noncompliance and Completely Non-ignorable Missing Data. The first international symposium on biopharmaceutical statistics. Shanghai, China.
76.July 1, 2008. The Efficiency of Clinical Trial Designs for Predictive Biomarker Validation. The first international symposium on biopharmaceutical statistics. Shanghai, China.
77.July 4, 2008. Selection and combination of biomarkers. Sichuan University. Chengdu, China.
78.June 30, 2008. Non-parametric heroscedastic transformation regression models for skewed data with an application to prediction of future health care costs. Fudan University. Shanghai, China.
79.March 24, 2008. Causal Inferences in Randomized Clinical Trials for Multi-component Interventions. Stanford University, Stanford, CA, USA.
80.January 18, 2008. Statistical and economic Prospectives on utilization, costs, and cost-effectiveness. The 7th International Conference on Health Policy Statistics – Striving for Consensus on Method. Philadelphia, PA, USA.
81.October 5, 2007. Direct semiparametric ROC regression models with unknown link and baseline functions. National Institute of Health. Bethesda, MD, USA.
82.October 4, 2007. Double-Semiparametric ROC Regression Analysis. Department of Statistics, George Mason University. Fairfax, VA, USA.
83.March 22, 2007. Non-parametric analysis of skewed data with heteroscedasticity. Department of Biostatistics, University of Michigan, MI, USA.
84. March 21, 2007. Non-parametric group sequential designs in diagnostic medicine. Department of Biostatistics, Duke University, Durham, NC, USA.
85.March 20, 2007. A new non-parametric method for predicting health care costs with Heteroscedasticity. Department of Biostatistics, University of North Carolina at Chapel Hills, Chapel Hills, NC, USA.
86.September 14, 2006. Nonparametric transformation regression models for skewed data with heteroscedastic variance. Department of Statistics and Actural Sciences. University of Waterloo, Canada.
87.August 8, 2006. Double-semiparametric ROC regression analysis. 2006 Joint Statistical Meetings. Seattle, USA.
88.July 9, 2006. New statistical methods in health economics. International Conference on Design of Experiments and Its Applications. Tianjin, China.
89. July 7, 2006. New statistical methods in diagnostic medicine. International Conference on Frontiers of Statistics -Biostatistics and Bioinformatics. Changchun, China.
90.June 23, 2006. Verification bias in assessment of accuracy of clinical diagnosis: importance and correction illustrated in a study of Alzheimer’s disease. 2nd North American Congress of Epidemiology 2006. Seattle, WA, USA.
91. April 20, 2006. Nonparametric transformation models with heteroscedastic variance. School of Statistics, University of Minnesota, Minneapolis, MN, USA.
92.March 29, 2006. Optimal estimation of ROC curves of continuous-scale tests. International Biometric Society Eastern Norther American Region, Tampa, FL.
93. Jan 27, 2006. Double semiparametric ROC regression models. Department of Biostatistics and Applied Mathematics, M.D. Anderson Cancer Center, University of Texas, Houston, TX, USA.
94. August 7, 2005. A Marginal model approach for analysis of multi-reader multi-test receiver operating characteristic (ROC) data. Joint Statistical Meetings. Minneapolis, MN, USA.
95.November 28, 2005. Semi-parametric maximum likelihood estimation of ROC curves. Department of Epidemiology and Biostatistics, University of California, San Fransciso, San Fransciso, CA, USA.
96.July 15, 2005. Statistical methods for analysis of missing data. School of Public Health. Sichuan University, Chengdu, China.
97. July 5, 2005. Case-mix adjusted facility profiling in the VA health care system. Guanghua School of Management. Peking University, Beijing, China.
98.July 3, 2005. Statistical methods in diagnostic medicine. Zhengzhou University School of Public Health, Zhengzhou, China.
99.June 28, 2005. Inferences in censored cost regression models with empirical likelihood. Chinese Academy of Science, Beijing, China.
100.June 27, 2005. Estimating the causal effect of flu shot for influenza in an encouragement design study. Department of Statistics and Probability. Peking University, Beijing, China.
101.June 22, 2005. Estimating the Retransformed Mean in a heteroscedastic Two-Part Model. Western North American Region of International Biometrical Society, Fairbanks, AK, USA.
102.May 27, 2005. Two-part Regression Models for Skewed Health Care Costs. Division of Biostatistics, Washington University, St. Louis, MO, USA.
103.March 21, 2005. Tips for handling good data with bad properties. Eastern North American Region of International Biometrical Society, Austin, TX, USA.
